306 related articles for article (PubMed ID: 24637544)
1. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.
Shah M; Ssengooba W; Armstrong D; Nakiyingi L; Holshouser M; Ellner JJ; Joloba M; Manabe YC; Dorman SE
AIDS; 2014 Jun; 28(9):1307-14. PubMed ID: 24637544
[TBL] [Abstract][Full Text] [Related]
2. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.
Shah M; Dowdy D; Joloba M; Ssengooba W; Manabe YC; Ellner J; Dorman SE
AIDS; 2013 Nov; 27(18):2883-92. PubMed ID: 25119690
[TBL] [Abstract][Full Text] [Related]
4. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
Lawn SD; Kerkhoff AD; Burton R; Schutz C; Boulle A; Vogt M; Gupta-Wright A; Nicol MP; Meintjes G
BMC Med; 2017 Mar; 15(1):67. PubMed ID: 28320384
[TBL] [Abstract][Full Text] [Related]
6. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
Lawn SD; Kerkhoff AD; Vogt M; Wood R
Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
[TBL] [Abstract][Full Text] [Related]
8. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
Nakiyingi L; Nonyane BA; Ssengooba W; Kirenga BJ; Nakanjako D; Lubega G; Byakika-Kibwika P; Joloba ML; Ellner JJ; Dorman SE; Mayanja-Kizza H; Manabe YC
PLoS One; 2015; 10(7):e0133756. PubMed ID: 26222142
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysis.
Dhana A; Hamada Y; Kengne AP; Kerkhoff AD; Broger T; Denkinger CM; Rangaka MX; Gupta-Wright A; Fielding K; Wood R; Huerga H; Rücker SCM; Bjerrum S; Johansen IS; Thit SS; Kyi MM; Hanson J; Barr DA; Meintjes G; Maartens G
J Infect; 2022 Jul; 85(1):40-48. PubMed ID: 35588942
[TBL] [Abstract][Full Text] [Related]
10. Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children.
LaCourse SM; Pavlinac PB; Cranmer LM; Njuguna IN; Mugo C; Gatimu J; Stern J; Walson JL; Maleche-Obimbo E; Oyugi J; Wamalwa D; John-Stewart G
AIDS; 2018 Jan; 32(1):69-78. PubMed ID: 29028662
[TBL] [Abstract][Full Text] [Related]
11. An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag.
Esmail A; Pooran A; Sabur NF; Fadul M; Brar MS; Oelofse S; Tomasicchio M; Dheda K
J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32727831
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce.
Peter JG; Theron G; Muchinga TE; Govender U; Dheda K
PLoS One; 2012; 7(7):e39966. PubMed ID: 22815718
[TBL] [Abstract][Full Text] [Related]
13. Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia.
Siddiqi OK; Birbeck GL; Ghebremichael M; Mubanga E; Love S; Buback C; Kosloff B; Ayles H; Atadzhanov M; Dheda K; Koralnik IJ
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189584
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
Yakhelef N; Audibert M; Ferlazzo G; Sitienei J; Wanjala S; Varaine F; Bonnet M; Huerga H
PLoS One; 2020; 15(1):e0227138. PubMed ID: 31999746
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of Lipoarabinomannan and Xpert MTB/RIF Testing in Cerebrospinal Fluid To Diagnose Tuberculous Meningitis in an Autopsy Cohort of HIV-Infected Adults.
Cox JA; Lukande RL; Kalungi S; Van Marck E; Lammens M; Van de Vijver K; Kambugu A; Nelson AM; Colebunders R; Manabe YC
J Clin Microbiol; 2015 Aug; 53(8):2667-73. PubMed ID: 26063865
[TBL] [Abstract][Full Text] [Related]
16. Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.
Gina P; Randall PJ; Muchinga TE; Pooran A; Meldau R; Peter JG; Dheda K
BMC Infect Dis; 2017 May; 17(1):339. PubMed ID: 28499418
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
[TBL] [Abstract][Full Text] [Related]
18. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
[TBL] [Abstract][Full Text] [Related]
19. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
[TBL] [Abstract][Full Text] [Related]
20. Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.
Nathavitharana RR; Lederer P; Chaplin M; Bjerrum S; Steingart KR; Shah M
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014641. PubMed ID: 34416013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
